Title of article
CDK9 Inhibitors Push Cancer Cells over the Edge
Author/Authors
Matthew W. Nowicki، نويسنده , , Malcolm D. Walkinshaw، نويسنده ,
Issue Information
ماهنامه با شماره پیاپی سال 2010
Pages
2
From page
1047
To page
1048
Abstract
The trouble with CDK active-site inhibitors is their tendency to have off-target effects. This is not surprising, as the ATP binding sites of most protein kinases are very similar. have used some clever screening approaches to identify selective CDK9 inhibitors that drive cancer cells into apoptosis.
Journal title
Chemistry and Biology
Serial Year
2010
Journal title
Chemistry and Biology
Record number
1159932
Link To Document